Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.06
Delayed Data
As of Feb 23
 +0.47 / +1.40%
Today’s Change
28.74
Today|||52-Week Range
37.39
+4.86%
Year-to-Date
Manchester mulls paying for medicines based on their efficacy
7:09am / FT.com - Paid Partner Content
Who Could Buy Bristol-Myers Squibb?
Feb 22 / MotleyFool.com - Paid Partner Content
Dow Jones Leads Market Gains on Thursday
Feb 23 / GuruFocus News - Paid Partner Content
Pfizer's Leukemia Candidate Gets Priority Review in U.S.
Feb 22 / Zacks.com - Paid Partner Content
Why 3D Printing and Biotech Will Be Good Bets in 2017
Feb 23 / GuruFocus News - Paid Partner Content
Gilead Sciences Raises Dividend by Double Digits
Feb 22 / GuruFocus News - Paid Partner Content
Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems
Feb 23 / MotleyFool.com - Paid Partner Content
Drug Addiction Treatment Stocks to Watch
Feb 22 / GuruFocus News - Paid Partner Content
Clovis (CLVS) Q4 Loss Wider than Expected; Focus on Rubraca
Feb 23 / Zacks.com - Paid Partner Content
These 10 stocks dominate the market
Feb 22 / CNNMoney.com

Today’s Trading

Previous close33.59
Today’s open33.70
Day’s range33.58 - 34.12
Volume30,477,129
Average volume (3 months)27,302,425
Market cap$206.7B
Dividend yield3.76%
Data as of 02/23/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.97%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+8.13%
P/E ratio34.1
Price/Sales3.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.56+0.86%
NVSNovartis+0.60+0.78%
SNYSanofi-0.01-0.02%
GSKGlaxoSmithKline+0.46+1.12%
Data as of 4:02pm ET, 02/23/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.67
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs